Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
Launched by UNIVERSITY HOSPITAL AUGSBURG · Dec 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two types of gastroscopes—one-time use and reusable—used in patients who have upper gastrointestinal bleeding, which means bleeding in the stomach or the part of the intestine closest to the stomach. The goal is to see if one type of scope works better than the other for diagnosing and treating this condition.
To take part in the study, participants must be between the ages of 65 and 74 and show certain signs of bleeding that are serious enough to need medical attention. They should have a specific score on a test that helps doctors determine the severity of their condition. However, pregnant individuals and those who cannot give consent will not be able to join. If you participate, you can expect to have either a single-use or a reusable gastroscope used during your procedure, and the study will help researchers understand which option may be more effective for patients in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Glasgow-Blatchford score (GBS) \>2
- • Clinical signs of upper bleeding
- Exclusion Criteria:
- • pregnancy
- • Unable to provide consent
About University Hospital Augsburg
University Hospital Augsburg is a leading academic medical center located in Augsburg, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between multidisciplinary teams of researchers, clinicians, and patients. With a commitment to enhancing patient outcomes and contributing to the global medical community, University Hospital Augsburg emphasizes ethical standards, patient safety, and the development of novel therapeutic approaches in various fields of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augsburg, Bavaria, Germany
Patients applied
Trial Officials
Christoph Römmele, MD
Principal Investigator
Unervsity Hospital Augsburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported